Navigation Links
Cliniqa Corporation Completes Asset Acquisition of Reagents Applications, Inc.

SAN MARCOS, Calif., Oct. 29 /PRNewswire/ -- Cliniqa Corporation (San Marcos, CA), a manufacturer of in-vitro diagnostic products, is pleased to announce the acquisition of the primary assets of Reagents Applications, Inc. "Raichem" (San Diego, CA), a wholly owned subsidiary of Hemagen Diagnostics, Inc. (Columbia, MD). Raichem is a manufacturer of clinical diagnostic products focusing on clinical chemistry reagents, calibrators, and controls. "The acquisition of Raichem and its comprehensive line of chemistry reagents, will allow CLINIQA to expand its liquid reagent offerings while adding lyophilization and dry powder manufacturing capabilities," states Granger Haugh, founder and Chief Executive Officer of Cliniqa Corporation.

"The acquisition of Raichem complements two previous acquisitions (Compass Bioscience and King Diagnostics, Inc.) completed within the last ninety days, and allows CLINIQA to offer an expanded portfolio of products and services to our customers. We can better leverage our liquid stabilization techniques and expertise within our technical organization," said Kevin Gould, President of Cliniqa Corporation.


CLINIQA, an ISO 13485:2003 certified company, is a manufacturer of reagents, calibrators, controls, and calibration verification products serving the in-vitro diagnostic industry. CLINIQA also supplies antisera, biochemicals, plasma, serum and contract manufacturing services for in-vitro diagnostic manufacturers. The company features proprietary True Liquid Control Technology in its products. CLINIQA is also the co-founder of "The Quality Alliance," formed to provide a range of innovative quality control products and an online Quality Analysis Peer Review application, InterQC, through common distribution channels in Europe, the U.S.A and Asia. Additional information may be found at or contact the U.S. headquarters:

Tel: 1 800 728 5205 (within U.S.A)

+1 760 744 1900 (outside U.S.A)

Fax: +1 760-736-3773


Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Trouble-shooting: Misincorporation or low fidelity
2. Roche Diagnostics Corporation
3. Roche Diagnostics Corporation
4. Promega Corporation: Wisconsins quiet innovator
5. Giuliani will keynote RedPrairie Corporations user conference
6. Madison Development Corporation makes loans to three area companies
7. Corporations and blogging
8. Metavante acquires Florida banking corporation
9. TriMas Corporations Cequent Group Acquires Chem-Chrome, Inc.
10. Sonic Foundry completes $11.25M stock offer
11. Orion Energy completes $5M capital round
Post Your Comments:
(Date:11/30/2015)... NORTH CHICAGO, Ill. , Nov. 30, 2015 /PRNewswire/ ... an all-inclusive program that focuses on a daily routine ... how patients take their medication can affect the way ... establish and follow to their a daily routine are ... is to help patients better manage their hypothyroidism ...
(Date:11/30/2015)... TIKVAH, Israel , Nov. 30, 2015 /PRNewswire/ ... a leading developer of adult stem cell technologies for neurodegenerative ... Ltd., has been awarded an additional grant of approximately $735,000 ... Scientist (OCS). This grant, the second this year, brings the ... approximately $1.8 million (approximately NIS7 million).  ...
(Date:11/27/2015)... India , November 27, 2015 /PRNewswire/ ... --> Growing popularity of companion diagnostics ... in cancer biomarkers market with pharmaceutical companies ... in-demand companion diagnostic tests. ... --> Complete report on global cancer ...
(Date:11/25/2015)... ANNAPOLIS, Md. , Nov. 25, 2015  PharmAthene, ... of Directors has adopted a stockholder rights plan (Rights ... its net operating loss carryforwards (NOLs) under Section 382 ... --> --> PharmAthene,s use of its ... an "ownership change" as defined in Section 382 of ...
Breaking Biology Technology:
(Date:11/20/2015)... 20, 2015 NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... , was recently interviewed on The RedChip Money ... this weekend on Bloomberg Europe , Bloomberg Asia, ... --> NXTD ) ("NXT-ID" or the "Company"), a ...
(Date:11/18/2015)... York , November 18, 2015 ... Research has published a new market report titled  Gesture ... Trends, and Forecast, 2015 - 2021. According to the report, ... 2014 and is anticipated to reach US$29.1 bn by ... 2021. North America dominated ...
(Date:11/17/2015)... EASTON, Mass. , Nov. 17, 2015 ... a leader in the development and sale of broadly ... the worldwide life sciences industry, today announced it has ... of its $5 million Private Placement (the "Offering"), increasing ... to $4,025,000.  One or more additional closings are expected ...
Breaking Biology News(10 mins):